首页> 中文期刊> 《中国免疫学杂志》 >姜黄素通过抑制STAT3通路调控人结肠癌耐奥沙利铂细胞株的耐药性

姜黄素通过抑制STAT3通路调控人结肠癌耐奥沙利铂细胞株的耐药性

         

摘要

目的::探讨姜黄素( Cur)对人结肠癌耐奥沙利铂( Oxa)细胞株( SW620/OxR)的逆转耐药作用及其机制是否与抑制STAT3信号通路有关。方法:采用WST-1试剂检测Cur对SW620/OxR细胞株的半数抑制( IC50)浓度,选择IC50低一浓度梯度的Cur+2μmol/L Oxa作用于SW620/OxR细胞48 h(称为实验组),与仅加入2μmol/L的Oxa对照组比较,①采用流式细胞术检测细胞凋亡;②采用Western blot检测STAT3活化标志磷酸化STAT3( P-STAT3)蛋白及其下游耐药相关靶分子P糖蛋白( P-gp)的表达情况。结果:Cur对SW620/OxR细胞的IC50浓度为18.9μmol/L;实验组与对照组比较:①细胞凋亡率由(5.08±1.82)%上升到(30.69±2.94)%,实验组细胞凋亡率明显高于对照组(P<0.05);②P-STAT3及P-gp表达量均明显受抑制( P<0.05)。结论:Cur具有调控人结肠癌耐药细胞株耐药性的作用,可能与抑制STAT3信号通路,降低P-gp表达有关。%Objective:To investigate the reversal multidrug resistance effects of curcumin on human colorectal cancer cell lines resistant to oxaliplatin( SW620/OxR) and whether its mechanism was involved in downregulation of STAT3 signaling.Methods: The IC50 value(50%cell growth inhibitory concentrations) of curcumin to SW620/OxR cell lines was obtained by WST-1 reagent,which was one kind of cell proliferation assay.Later experiments included in the experimental group and the control group.In the experimental group,SW620/OxR cell lines were exposed to the previous experiment IC50 concentrations of curcumin plus 2 μmol/L oxaliplatin for 48 h,while in the control group,SW620/OxR cell lines were cultured in medium containing in 2μmol/L oxaliplatin.In the two groups:apoptosis was detected by flow cytometry;the protein expression levels of phosphorylated STAT3(P-STAT3) and P-gp were disclosed by Western blot.Results:The IC50 value of curcumin to SW620/OxR cell lines was 18.9 μmol/L.The apoptosis rate of cells in the control group and the experimental group were respectively ( 5.08 ±1.82 )% and ( 30.69 ±2.94 )%, the apoptosis rate of the experimental group was significantly higher than that of the control group ( P<0.05 ) .The protein expression levels of phosphorylated STAT3(P-STAT3) and P-gp in the experimental group was significantly lower than that in the control group(P<0.05).Conclusion:Curcumin can reverse drug resistance in colorectal cancer cell lines resistant to oxaliplatin, its effect may be associated with downregulation of STAT3 signaling pathways.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号